Last reviewed · How we verify
NCT04017364: SCBDNMAL
Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter Malaysia
NA trial testing PCB PTCA in Coronary Artery Disease in 70 participants. Completed in 31 January 2021.
30 August 2020
Quick facts
| Lead sponsor | InnoRa GmbH |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 July 2019 |
| Primary completion | 30 August 2020 |
| Estimated completion | 31 January 2021 |
| Sites | 6 locations across Malaysia |
Drugs / interventions tested
- PCB PTCA
- SCB PTCA
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
InnoRa GmbH
Who can join
18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To examine the treatment of coronary de-novo stenosis with a sirolimus coated balloon versus a paclitaxel coated balloon
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon.
Ahmad WAW, Nuruddin AA, Abdul Kader MASK, Ong TK, et al · · 2022 · cited 64× · PMID 35305906 · DOI 10.1016/j.jcin.2022.01.012
Verify or expand the search:
- PubMed search for NCT04017364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other InnoRa GmbH trials
Trials by the same sponsor.
- NCT05445258 — Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon · NA · terminated
- NCT03908450 — Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter · NA · completed
- NCT03242096 — Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon · NA · completed
- NCT03332264 — Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions · NA · completed
- NCT02996318 — Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04017364 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by InnoRa GmbH
- Last refreshed: 27 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04017364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing